Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2011; 17(14): 1903-1909
Published online Apr 14, 2011. doi: 10.3748/wjg.v17.i14.1903
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Liver histology in a cirrhotic rat model (HE staining, × 200).
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Mucosal morphology of ileal tissue in normal control group (A), non-treatment group (B), low-dose salvianolate treatment group (C), medium-dose salvianolate treatment group (D), and high-dose salvianolate treatment group (E) (HE staining, × 100).
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Electrophoretograms of tumor necrosis factor-α (A) and IL-6 (B). M: Marker; lane 1: Normal control group; lane 2: Untreated group; lane 3: Low-dose salvianolate-treated group; lane 4: Medium-dose salvianolate-treated group; lane 5: High-dose salvianolate-treated group.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Real-time reverse transcription polymerase chain reaction for the expression of relative mRNA level of TNF and IL-6 in normal control group (A), non-treatment group (B), low-dose salvianolate treatment group (C), medium-dose salvianolate treatment group (D), and high-dose salvianolate treatment group (E). TNF: Tumor necrosis factor; IL: Interleukins.